Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study.
Author(s): Boylan GB, Rennie JM, Chorley G, Pressler RM, Fox GF, Farrer K, Morton M, Binnie CD
Affiliation(s): Department of Child Health, Guy's King's St Thomas' School of Medicine, London, UK. g.boylan@ucc.ie
Publication date & source: 2004-02-10, Neurology., 62(3):486-8.
Publication type: Clinical Trial; Randomized Controlled Trial
The authors conducted a randomized trial of second-line anticonvulsant treatments for neonates. The response to treatment was assessed using continuous video-EEG because the clinical diagnosis of seizure in neonates is known to be unreliable. Of 27 neonates with EEG-confirmed seizures, 5 were excluded because of protocol violations, and 11 responded to phenobarbitone in a dose of 40 mg/kg as first line. Three of five neonates treated with lignocaine responded. Six neonates were treated with benzodiazepines as second line: None responded, and their neurodevelopmental outcome was poor.
|